You are here

Therapeutic goods advertising code

The Therapeutic Goods Advertising Code (the Code) ensures that the marketing and advertising of therapeutic goods is conducted in a manner that promotes the quality use of the product, is socially responsible and does not mislead or deceive the consumer.

The Therapeutic Goods Administration administers the Code.

Current version of the Code

The Therapeutic Goods Advertising Code 2015 took effect on 14 November 2015 and is available from the Federal Register of Legislation. The 2015 Code will cease operation on 31 December 2018.

Future version of the Code

On 1 January 2019, the Therapeutic Goods Advertising Code (No. 2) 2018 will take effect.

Important background and related information about the Therapeutic Goods Advertising Code (No. 2) 2018 is available from Therapeutic goods advertising: Update 31 October 2018

Information about the changeover to the 2018 Code, including which code is applied in the consideration of advertising approvals and complaints, is available from Changeover to the new Therapeutic Goods Advertising Code. Information about our approach to enforcement discretion during 2019 is available from the Therapeutic goods advertising: Update 29 October 2018.

Code guidance

The Therapeutic Goods Advertising Code 2018 is supported by guidance, Complying with the Therapeutic Goods Advertising Code (No. 2) 2018

Previous versions of the TGAC

Amendments to the TGAC

Information about amendments to the Code over 5 years old can be found in the TGA Internet site archive.